Hookworm Infections

Phase 4 trials (6)

• albendazole
• ivermectin
• mebendazole
• pyrequan
• oxantel
• moxidectin

Phase 3 trials (3)

• emodepside
• piperaquine
• dihydroartemisinin

Phase 2 trials (5)

• cpg 10104
• necator americanus
• aluminum hydroxide
• gla-af
• na-gst-1

Phase 1 trials (4)

• gluco-pyranosylphospho-lipid
• hepatitis b vaccine (recombinant)
• na-apr-1
• na-asp-2

Other trials (1)

• iron

Organization Involved with Phase 4 Indications (8)

• Ghana Health Services
• University of Ghana
• Yale University
• Kintampo Health Research Centre, Ghana
• Noguchi Memorial Institute for Medical Research
• University of Basel
• PATH
• HopeXchange Medical Center, Ghana

Organization Involved with Phase 2 Indications (4)

• National Institute of Allergy and Infectious Diseases (NIAID)
• Baylor University
• George Washington University
• Centre Suisse de Recherches Scientifiques en Côte d'Ivoire (CSRS)

Organization Involved with Phase 1 Indications (10)

• Albert B. Sabin Vaccine Institute
• University of London
• Johns Hopkins University
• Centre de Recherche Médicale de Lambaréné
• University of California, San Francisco
• Leiden University
• University of Amsterdam
• Children's National Medical Center
• Bill and Melinda Gates Foundation
• Oswaldo Cruz Foundation

Organization Involved with Other Experimental Indications (10)

• Swiss Federal Institute of Technology
• Salmon, Margaret, M.D.
• University of Toronto
• Western New England University
• Universidad del Valle de Guatemala
• MERTU/CDC-Universite de Valle de Guatemala
• Akeso Associates
• Eastern Congo Initiative
• HEAL Africa Hospital, Goma, Democratic Republic of Congo
• Centers for Disease Control and Prevention (CDC)